Abstract:OBJECTIVE To develop a standard duck hepatitis B virus (DHBV) animal model using a local Hubei species of duck, Ma Ya, and use it as an in vivo experimental system to study antiviral strategies against hepatitis B. METHODS Two-day-old Ma Ya ducklings were experimentally infected via intraperitoneal injection with the DHBV inocula which was collected from the transfected culture supernatant of 1.5-fold-overlength genome recombinant plasmid. Blood samples were taken twice or thrice a week during post-inoculation for 50 days. Viremia was quantified by serum real-time PCR to show the peak. Antiviral treatment of the DHBV-infected ducklings was started 3 d post-inoculation. The animals received oral administration of lamivudine (3TC) at a dose of 25 mg/kg/d for 5 d, followed by a maintenance therapy thrice weekly for 3 more weeks. Serum was quantified to show the viremia peak and liver biopsy specimens were analysed by Southern blotting and in-situ hybridization at the end of antiviral drug treatment. RESULTS The experimental infection rate of 2-day-old ducklings was 87.5%. Viremia started to be detectable on day 7 and reached a peak on day 11 post-inoculation, followed by a decrease and fluctuations. Four weeks of oral administration of 3TC led to a significant decrease in viremia peak during. This effect was not sustained, as a rebound in viremia was observed after drug withdrawal. Similarly, the analysis of liver biopsies at the end of 3TC treatment showed a marked decrease in DHBV DNA. However, after drug withdrawal a rebound of intrahepatic DHBV DNA was observed in duck livers. CONCLUSION The Hubei duck model with experimental DHBV infection of transfected supernatant is more suitable for the hepadnavirus biologic research due to its stability and practicability.

Cloning and Sequence Analysis of Duck Hepatitis B Virus Genome from Hubei Brown Ducks

Molecular characterization of duck hepatitis B virus isolated from Hubei brown ducks

Complete Genome Sequence of the Novel Duck Hepatitis B Virus Strain SCP01 from Sichuan Cherry Valley Duck

Isolation and identification,and complete-genome phylogenetic analysis of Duck hepatitis B virus strains from Muscovy duck

ISOLATION IDENTIFICATION AND SEQUENCE ANALYSIS FOR THE COMPLETE GENOME OF DUCK HEPATITIS VIRUS 1 SG STRAIN

Genomic Sequence Analysis of Three Strains of Duck Hepatitis Virus Type 1

Identification and molecular analysis of the highly pathogenic duck hepatitis virus type 1 in Hubei province of China.

Sequencing and analysis of genome of duck hepatitis virus isolated from China

Identification of Natural Recombination in Duck Hepatitis B Virus

Genomic Sequence of a New Serotype Duck Hepatitis Virus

Molecular Characterization and Phylogenetic Analysis of H3 Subtype Avian Influenza Viruses Isolated from Domestic Ducks in Zhejiang Province in China.

Isolation and identification of duck hepatitis virus and its physical-chemical and biological characteristics

Sequencing and Molecular Analysis of Duck Hepatitis Virus Type 1, Strain F

Cloning, Expression and Purification of Duck Hepatitis B Virus (DHBV) Core Protein and Its Use in the Development of an Indirect ELISA for Serologic Detection of DHBV Infection

Integrated structures of duck hepatitis B virus DNA in hepatocellular carcinoma

Isolation and Identification of A Serotype Ⅰ Duck Hepatitis Genotype C Virus

Classification of Duck Hepatitis Virus into Three Genotypes Based on Molecular Evolutionary Analysis

Generation of Infectious and Pathogenic Duck Hepatitis Virus Type 1 from Cloned Full-Length Cdna

Complete Genome Sequence of a Duck Hepatitis A Virus Type 3 Identified in Eastern China

Complete Genome Sequence of a Novel Duck Hepatitis A Virus Discovered in Southern China

Establishment of an in Vivo Model for Duck Hepatitis B Virus Infection Using Hubei Duckling